Estado del programa
Activo, no reclutaFase
Fase 1Inmunoterapia previa permitida
SíEnsayo dirigido por el CRC
SíDrogas
Atezolizumab, CabozantinibEtiquetas
MSS/ MMRpUbicación | Situación |
---|---|
Estados Unidos | |
Exelixis Clinical Site #53 Gilbert, Arizona 85234 |
Activo, no recluta |
Exelixis Clinical Site #18 Phoenix, Arizona 85054 |
Activo, no recluta |
Exelixis Clinical Site #1 Duarte, California 91010 |
Activo, no recluta |
Exelixis Clinical Site #20 La Jolla, California 92090 |
Activo, no recluta |
Exelixis Clinical Site #46 Los Angeles, California 90025 |
Activo, no recluta |
Exelixis Clinical Site #51 Newport Beach, California 92663 |
Activo, no recluta |
Exelixis Clinical Site #62 Santa Monica, California 90404 |
Activo, no recluta |
Exelixis Clinical Site #21 Stanford, California 94305 |
Activo, no recluta |
Exelixis Clinical Site #34 Denver, Colorado 80218 |
Activo, no recluta |
Exelixis Clinical Site #50 Denver, Colorado 80218 |
Activo, no recluta |
Exelixis Clinical Site #42 New Haven, Connecticut 06511 |
Activo, no recluta |
Exelixis Clinical Site #48 Washington, Distrito de Columbia 20007 |
Activo, no recluta |
Exelixis Clinical Site #16 Jacksonville, Florida 32224 |
Activo, no recluta |
Exelixis Clinical Site #76 Tampa, Florida 33612 |
Activo, no recluta |
Exelixis Clinical Site #60 Atlanta, Georgia 30318 |
Activo, no recluta |
Exelixis Clinical Site #79 Atlanta, Georgia 30341 |
Activo, no recluta |
Exelixis Clinical Site #32 Harvey, Illinois 60426 |
Activo, no recluta |
Exelixis Clinical Site #23 Fairway, Kansas 66205 |
Activo, no recluta |
Exelixis Clinical Site #57 Lexington, Kentucky 40536 |
Activo, no recluta |
Exelixis Clinical Site #24 New Orleans, Louisiana 70112 |
Activo, no recluta |
Exelixis Clinical Site #10 Boston, Massachusetts 02215 |
Activo, no recluta |
Exelixis Clinical Site #3 Detroit, Michigan 48201 |
Activo, no recluta |
Exelixis Clinical Site #17 Rochester, Minnesota 55905 |
Activo, no recluta |
Exelixis Clinical Site #65 Bolivar, Missouri 65613 |
Activo, no recluta |
Exelixis Clinical Site #43 Kansas City, Missouri 64111 |
Activo, no recluta |
Exelixis Clinical Site #35 Omaha, Nebraska 68130 |
Activo, no recluta |
Exelixis Clinical Site #59 Omaha, Nebraska 68130 |
Activo, no recluta |
Exelixis Clinical Site #61 Las Vegas, Nevada 89169 |
Activo, no recluta |
Exelixis Clinical Site #38 Camden, Nueva Jersey 08103 |
Activo, no recluta |
Exelixis Clinical Site #27 East Brunswick, New Jersey 08816 |
Activo, no recluta |
Exelixis Clinical Site #31 New Brunswick, Nueva Jersey 08903 |
Activo, no recluta |
Exelixis Clinical Site #37 Bronx, Nueva York 10461 |
Activo, no recluta |
Exelixis Clinical Site #40 East Setauket, New York 11733 |
Activo, no recluta |
Exelixis Clinical Site #11 Nueva York, Nueva York 10029 |
Activo, no recluta |
Exelixis Clinical Site #67 Cleveland, Ohio 44195 |
Activo, no recluta |
Exelixis Clinical Site #49 Columbus, Ohio 43210 |
Activo, no recluta |
Exelixis Clinical Site #64 Kettering, Ohio 45409 |
Activo, no recluta |
Exelixis Clinical Site #71 Oklahoma City, Oklahoma 73104 |
Activo, no recluta |
Exelixis Clinical Site #6 Oklahoma City, Oklahoma 73120 |
Activo, no recluta |
Exelixis Clinical Site #102 Portland, Oregón 97213 |
Activo, no recluta |
Exelixis Clinical Site #45 Portland, Oregon 97239 |
Activo, no recluta |
Exelixis Clinical Site #41 Bethlehem, Pennsylvania 18015 |
Activo, no recluta |
Exelixis Clinical Site #15 Filadelfia, Pensilvania 19107 |
Activo, no recluta |
Exelixis Clinical Site #55 Philadelphia, Pennsylvania 19111 |
Activo, no recluta |
Exelixis Clinical Site #66 Pittsburgh, Pensilvania 15232 |
Activo, no recluta |
Exelixis Clinical Site #95 Charleston, South Carolina 29414 |
Activo, no recluta |
Exelixis Clinical Site #13 Dallas, Texas 75246 |
Activo, no recluta |
Exelixis Clinical Site #26 Dallas, Texas 75390 |
Activo, no recluta |
Exelixis Clinical Site #114 Fort Worth, Texas 76104 |
Activo, no recluta |
Exelixis Clinical Site #29 Houston, Texas 77030 |
Activo, no recluta |
Exelixis Clinical Site #39 Houston, Texas 77030 |
Activo, no recluta |
Exelixis Clinical Site #44 Houston, Texas 77030 |
Activo, no recluta |
Exelixis Clinical Site #33 Lubbock, Texas 79410 |
Activo, no recluta |
Exelixis Clinical Site #63 San Antonio, Texas 78229 |
Activo, no recluta |
Exelixis Clinical Site #2 Salt Lake City, Utah 84112 |
Activo, no recluta |
Exelixis Clinical Site #30 Blacksburg, Virginia 24060 |
Activo, no recluta |
Exelixis Clinical Site #14 Charlottesville, Virginia 22908 |
Activo, no recluta |
Australia | |
Exelixis Clinical Site #98 Albury, New South Wales 2640 |
Activo, no recluta |
Exelixis Clinical Site #101 Camperdown, New South Wales 2050 |
Activo, no recluta |
Exelixis Clinical Site #115 Gosford, New South Wales 2250 |
Activo, no recluta |
Exelixis Clinical Site #112 North Ryde, New South Wales 2109 |
Activo, no recluta |
Exelixis Clinical Site #123 Randwick, Nueva Gales del Sur 2031 |
Activo, no recluta |
Exelixis Clinical Site #99 St Albans, Victoria 3021 |
Activo, no recluta |
Bélgica | |
Exelixis Clinical Site #52 Gante 9000 |
Activo, no recluta |
Exelixis Clinical Site #54 Lovaina 3000 |
Activo, no recluta |
Francia | |
Exelixis Clinical Site #88 La Roche-sur-Yon, Cedex 9 85925 |
Activo, no recluta |
Exelixis Clinical Site #8 Villejuif, Cedex 94805 |
Activo, no recluta |
Exelixis Clinical Site #92 Burdeos 33076 |
Activo, no recluta |
Exelixis Clinical Site #93 Brest 29229 |
Activo, no recluta |
Exelixis Clinical Site #87 CAEN Cedex 05 14076 |
Activo, no recluta |
Exelixis Clinical Site #69 Le Mans 72000 |
Activo, no recluta |
Exelixis Clinical Site #97 Lille 59000 |
Activo, no recluta |
Exelixis Clinical Site #89 Lyon Cedex 08 69373 |
Activo, no recluta |
Exelixis Clinical Site #109 Marseille 13273 |
Activo, no recluta |
Exelixis Clinical Site #104 Nice Cedex 02 06189 |
Activo, no recluta |
Exelixis Clinical Site #80 Nîmes Cedex 09 30029 |
Activo, no recluta |
Exelixis Clinical Site #78 Paris 75005 |
Activo, no recluta |
Exelixis Clinical Site #7 París 75010 |
Activo, no recluta |
Exelixis Clinical Site #68 Paris 75013 |
Activo, no recluta |
Exelixis Clinical Site #72 París 75015 |
Activo, no recluta |
Exelixis Clinical Site #82 Saint-Grégoire 35760 |
Activo, no recluta |
Exelixis Clinical Site #119 Strasbourg 67000 |
Activo, no recluta |
Exelixis Clinical Site #107 Suresnes 92150 |
Activo, no recluta |
Exelixis Clinical Site #105 Vandoeuvre les nancy 54519 |
Activo, no recluta |
Alemania | |
Exelixis Clinical Site #56 Düsseldorf, Nordrhein-Westfalen 40225 |
Activo, no recluta |
Exelixis Clinical Site #36 Tubinga 72076 |
Activo, no recluta |
Italia | |
Exelixis Clinical Site #84 Meldola, FC 47014 |
Activo, no recluta |
Exelixis Clinical Site #47 Rozzano, Milán 20089 |
Activo, no recluta |
Exelixis Clinical Site #108 Milán 20132 |
Activo, no recluta |
Exelixis Clinical Site #103 Milano 20133 |
Activo, no recluta |
Exelixis Clinical Site #25 Milano 20133 |
Activo, no recluta |
Exelixis Clinical Site #4 Milano 20133 |
Activo, no recluta |
Exelixis Clinical Site #85 Nápoles 80131 |
Activo, no recluta |
Exelixis Clinical Site #121 Pavia 27100 |
Activo, no recluta |
Exelixis Clinical Site #110 Roma 00168 |
Activo, no recluta |
Países Bajos | |
Exelixis Clinical Site #12 Nijmegen, Gelderland 6525 GA |
Activo, no recluta |
España | |
Exelixis Clinical Site #74 Santiago De Compostela, A Coruña 15706 |
Activo, no recluta |
Exelixis Clinical Site #91 Elche, Alicante 03203 |
Activo, no recluta |
Exelixis Clinical Site #94 Oviedo, Asturias 33011 |
Activo, no recluta |
Exelixis Clinical Site #70 Palma De Mallorca, Baleares 07120 / 07010 |
Activo, no recluta |
Exelixis Clinical Site #113 Badalona, Barcelona 08916 |
Activo, no recluta |
Exelixis Clinical Site #116 Sabadell, Barcelona 08208 |
Activo, no recluta |
Exelixis Clinical Site #96 Jeréz De La Frontera, Cádiz 11407 |
Activo, no recluta |
Exelixis Clinical Site #90 Pamplona, Navarra 31008 |
Activo, no recluta |
Exelixis Clinical Site #117 La Laguna, Santa Cruz De Tenerife 38320 |
Activo, no recluta |
Exelixis Clinical Site #75 Barcelona 08003 |
Activo, no recluta |
Exelixis Clinical Site #58 Barcelona 08022 |
Activo, no recluta |
Exelixis Clinical Site #83 Barcelona 08023 |
Activo, no recluta |
Exelixis Clinical Site #86 Barcelona 08025 |
Activo, no recluta |
Exelixis Clinical Site #28 Barcelona 08035 |
Activo, no recluta |
Exelixis Clinical Site #9 Barcelona 08035 |
Activo, no recluta |
Exelixis Clinical Site #73 Barcelona 08036 |
Activo, no recluta |
Exelixis Clinical Site #118 Girona 17007 |
Activo, no recluta |
Exelixis Clinical Site #77 Madrid 28034 |
Activo, no recluta |
Exelixis Clinical Site #106 Madrid 28040 |
Activo, no recluta |
Exelixis Clinical Site #111 Madrid 28040 |
Activo, no recluta |
Exelixis Clinical Site #22 Madrid 28041 |
Activo, no recluta |
Exelixis Clinical Site #5 Madrid 28041 |
Activo, no recluta |
Exelixis Clinical Site #81 Madrid 28046 |
Activo, no recluta |
Exelixis Clinical Site #100 Málaga 29010 |
Activo, no recluta |
Reino Unido | |
Exelixis Clinical Site #122 Middlesex, England HA6 2RN |
Activo, no recluta |
Exelixis Clinical Site #120 Preston, England PR2 9HT |
Activo, no recluta |
Exelixis Clinical Site #124 Cardiff, Wales CF14 2TL |
Activo, no recluta |
Exelixis Clinical Site #19 London EC1M 6BQ |
Activo, no recluta |
Criterios de inclusión
Criterios de inclusión:
Cytologically or histologically and radiologically confirmed solid tumor that is inoperable, locally advanced, metastatic, or recurrent:
Dose-Escalation Stage:
Subjects with UC (including renal pelvis, ureter, bladder, urethra) after prior platinum-based therapy, or
Subjects with RCC (clear cell, non-clear cell histology) with or without prior systemic anticancer therapy
Expansion Stage:
Inoperable locally advanced or metastatic solid tumor (UC, RCC, CRPC, NSCLC, TNBC, OC, EC, HCC, GC/GEJC/LEC, CRC, H&N cancer, and DTC as outlined above)
Measurable disease per RECIST 1.1 as determined by the investigator.
Tumor tissue material available (archival or recent tumor biopsy)
Recovery to baseline or ≤ Grade 1 CTCAE v4 from toxicities related to any prior treatments, unless AE(s) are clinically nonsignificant and/or stable on supportive therapy.
Age eighteen years or older on the day of consent.
Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
Adequate organ and marrow function.
Sexually active fertile subjects and their partners must agree to use medically accepted methods of contraception.
Female subjects of childbearing potential must not be pregnant at screening.
Criterios de exclusión
Criterios de exclusión:
Prior treatment with cabozantinib or immune checkpoint inhibitors including anti-CTLA-4, anti-PD-1, anti-PD-L1, or anti-PD-L2 therapy except in Expansion Cohorts 5, 7, 9, 11, 17, 19 and 20. Other restrictions regarding prior therapy may apply.
Known brain metastases or cranial epidural disease unless adequately treated and stable for at least 4 weeks before first dose of study treatment.
Concomitant anticoagulation with oral anticoagulants.
Subject is receiving systemic steroid therapy (>10 mg daily prednisone equivalent) or any other form of immunosuppressive therapy within 2 weeks prior to first dose of study treatment.
Administration of a live, attenuated vaccine within 30 days before first dose of study treatment.
The subject has uncontrolled, significant intercurrent or recent illness, including, but not limited to, an active or history of autoimmune disease or immune deficiency; idiopathic pulmonary fibrosis, organizing pneumonia, pneumonitis; active infection requiring systemic treatment, infection with human immunodeficiency virus (HIV), AIDS-related illness, acute or chronic hepatitis B or C infection, positive test for tuberculosis, moderate to severe hepatic impairment (Child-Pugh B or C).
Pregnant or lactating females.
Previously identified allergy or hypersensitivity to components of the study treatment formulations.
Diagnosis of another malignancy within 2 years before first dose of study treatment.